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Abstract
Background: Bacillus thuringiensis (Bt), an ubiquitous gram-positive spore-forming bacterium forms parasporal
proteins during the stationary phase of its growth. Recent findings of selective human cancer cell-killing activity in
non-insecticidal Bt isolates resulted in a new category of Bt parasporal protein called parasporin. However, little is
known about the receptor molecules that bind parasporins and the mechanism of anti-cancer activity. A Malaysian
Bt isolate, designated Bt18 produces parasporal protein that exhibit preferential cytotoxic activity for human
leukaemic T cells (CEM-SS) but is non-cytotoxic to normal T cells or other cancer cell lines such as human cervical
cancer (HeLa), human breast cancer (MCF-7) and colon cancer (HT-29) suggesting properties similar to parasporin.
In this study we aim to identify the binding protein for Bt18 in human leukaemic T cells.
Methods: Bt18 parasporal protein was separated using Mono Q anion exchange column attached to a HPLC
system and antibody was raised against the purified 68-kDa parasporal protein. Receptor binding assay was used
to detect the binding protein for Bt18 parasporal protein in CEM-SS cells and the identified protein was sent for
N-terminal sequencing. NCBI protein BLAST was used to analyse the protein sequence. Double
immunofluorescence staining techniques was applied to localise Bt18 and binding protein on CEM-SS cell.
Results: Anion exchange separation of Bt18 parasporal protein yielded a 68-kDa parasporal protein with specific
cytotoxic activity. Polyclonal IgG (anti-Bt18) for the 68-kDa parasporal protein was successfully raised and
purified. Receptor binding assay showed that Bt18 parasporal protein bound to a 36-kDa protein from the
CEM-SS cells lysate. N-terminal amino acid sequence of the 36-kDa protein was GKVKVGVNGFGRIGG. NCBI
protein BLAST revealed that the binding protein was Glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Double immunofluorescence staining showed co-localisation of Bt18 and GAPDH on the plasma membrane of
the CEM-SS cells.
Conclusions: GAPDH has been well known as a glycolytic enzyme, but recently GAPDH was discovered to have
roles in apoptosis and carcinogenesis. Pre-incubation of anti-GAPDH antibody with CEM-SS cells decreases binding
of Bt18 to the susceptible cells. Based on a qualitative analysis of the immunoblot and immunofluorescence results,
GAPDH was identified as a binding protein on the plasma membrane of CEM-SS cells for Bt18 parasporal protein.
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Bacillus thuringiensis (Bt) was initially characterised as
an insect pathogen, and its insecticidal activity was
attributed largely to parasporal proteins. Recent studies,
however, have reported that non-insecticidal Bt strains
are more widely distributed than insecticidal ones [1].
This raises the question of whether non-insecticidal
parasporal proteins have any biological activity which is
as yet undiscovered.
In a pioneering study, it was reported that selective
human cancer cell-killing activity is associated with
some non-insecticidal Bt isolates resulting in a new cate-
gory of Bt parasporal protein called parasporin. Para-
sporins are defined as bacterial parasporal proteins that
are capable of preferentially killing cancer cells [2,3].
Mizuki et al., (2000) obtained the first parasporin by
expressing the cry gene encoding the Cry31Aa protein
(also known as parasporin-1), which exhibits strong
cytotoxicity against human leukemic T cells (MOLT-4),
but did not exhibit insecticidal or hemolytic activities
[4]. This was followed by the identification of three
more proteins, Cry46Aa (parasporin-2), Cry41Aa (para-
sporin-3) and Cry45Aa (parasporin-4) also with selective
cytotoxic activities against cancer cells [5-7]. Recently
two more parasporin (PS5Aa1 and PS6Aa1) were added
in the parasporin nomenclature [8]. Interestingly, a
Malaysian Bt isolate, designated Bt18 produces para-
sporal protein that exhibit cytotoxic activity preferen-
tially for human leukaemic T cells (CEM-SS) but is
non-cytotoxic to normal T cells or other cancer cell
l i n e ss u c ha sH e L a ,M C F - 7a n dH T - 2 9[ 9 ] .I tw a s
reported that Bt18 parasporal protein is cytotoxic to
CEM-SS as 84% cell death was observed at 0.5 μg/mL
(CD50 value of 0.1224 ± 0.0092 μg/mL) [9]. Bt18 pro-
duces parasporal protein, which is also non-hemolytic to
human or rat erythrocytes after trypsin activation, shows
therapeutic and diagnostic potential with regards to leu-
kaemia. This finding has triggered interest in elucidating
t h em o d eo fa c t i o no fB t 1 8p a r a s p o r a lp r o t e i n .Q u e s -
tions arise on how Bt18 parasporal protein specifically
recognise leukaemic T cells. Insecticidal Bt parasporal
proteins are known to bind receptors on the insect
brush border membrane and it is suggested that these
receptors play a role in the specificity of insecticidal
activity [10,11].
We hypothesise that Bt18 cell killing activity is recep-
tor mediated in that Bt18 parasporal protein binds spe-
cifically to a binding protein on the plasma membrane.
To identify the binding protein, qualitative analysis were
performed on Bt18 and CEM-SS cells using immunoblot
and immunofluorescent staining. Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was identified as a
binding protein for Bt18.
Methods
Bacterial strains and growth conditions
The Bt isolates used in this study were from Institute
for Medical Research (IMR), Malaysia. Bt collections
and the subtypes were determined using H antigen ser-
otyping. Bt isolates used were Bt18, Bacillus thuringien-
sis 2( B t 2 ) ,a n dBacillus thuringiensis subsp jegathesan
(Btj). The Bt isolates were cultured in nutrient broth
supplemented with CaCl2 (0.01%), MgCl2 (0.08%) and
MnCl2 (0.07%) at 30°C until more than 95% sporulation
occurred.
Preparation of spore-crystal mixture
Sporulated Bt cultures was treated with 1 M NaCl to
osmotically lyse the bacterium to release the spore and
crystals. The spore-crystal mixture was harvested by
centrifugation at 13,000 g for 5 minutes, washed once
with NaCl and twice with ice-cold water. The spore-
crystal mixture was resuspended in Tris/KCl buffer
(pH 7.5) before storing at -20°C.
The parasporal protein was separated from spores by
ultracentrifugation of the spore-crystal mixture at
25000 g, 4°C for 16 hours on a discontinuous sucrose
density gradient of 67, 72 and 79% (w/v) in Tris/KCl
buffer (pH 7.5) [12].
Solubilisation and activation of parasporal protein
The parasporal protein was solubilised in sodium carbo-
nate buffer (pH 10.5) containing 10 mM DTT and acti-
vated with trypsin (1 mg/mL) for 1 hour at 37°C. The
activated parasporal protein was desalted and concen-
trated using Amicon® Ultra-4 centrifugal filter (Milipore).
Protein concentration was estimated using the method of
Bradford [13] using bovine serum albumin (BSA) as
standard.
Separation of Bt18 parasporal protein
The trypsin activated parasporal protein was separated
using Mono Q anion exchange column attached to a
HPLC system (Perkin Elmer Series 200). The column was
pre-equilibrated in 20 mM Piperazine buffer (pH 9.8).
Bound proteins were eluted with 0-1 M NaCl solution
and monitored at 280 nm. The eluted protein were ana-
lysed by SDS-PAGE and desalted using Amicon® Ultra-4
centrifugal filter (Milipore).
Polyclonal antibody production
The parasporal protein was separated by SDS-PAGE and
the 68-kDa protein was eluted from the gel by passive
elution, overnight in elution buffer (pH 7.5). Eluted pro-
tein was concentrated and desalted using Amicon®
Ultra-4 centrifugal filter. 100 μg/mL of the protein were
mixed with Freund’s complete adjuvant and injected
Krishnan et al. Journal of Biomedical Science 2010, 17:86
http://www.jbiomedsci.com/content/17/1/86
Page 2 of 11subcutaneously into 2 New Zealand White rabbits.
Three booster immunisations with incomplete Freunds
adjuvant were administered at 7 days, 28 days, and
42 days after primary immunisation. The ability of the
antibody developed against the 68-kDa protein was
determined by immunoblots. The anti-Bt18 antibody
was purified using Melon Gel IgG purification kit
(Pierce). Gravity-flow column procedure for antibody
purification was used. Purified antibody was examined
f o rp u r i t yb yS D S - P A G Ea n dprotein concentration of
IgG was determined by method of Bradford [13].
Immunoblot assay to detect the binding of anti-Bt18
antibody to Bt18 parasporal protein
Solubilised and activated Bt18 parasporal protein was
separated by SDS-PAGE and transferred to a nitrocellu-
lose membrane. The membrane was blocked in 5% BSA
in TBS, pH7.4 solution for 1 hour at room temperature.
The primary antibody anti-Bt18 antibody (1:1000) was
added and incubated for 1 hour at 37°C. The membrane
was washed 5 × 5 minutes washes with TBS (pH 7.4)
and incubated with secondary antibody HRP labeled
(1:5000) for 1 hour at room temperature. After washing
5 × 5 minutes washes with TBS (pH 7.4), the membrane
was developed with 4-chloro-1-naphtol substrate.
Culture of human T4-lymphoblastoid (CEM-SS) cell line
CEM-SS cells were grown at 37°C with 5% CO2 in
75 mL tissue culture flask (Nunc) in RPMI 1640
supplemented with 10% fetal bovine serum, 0.1% sodium
pyruvate, 0.1% HEPES, 0.1% glutamine and 1% penicil-
lin-streptomycin.
Detection of Bt18 parasporal protein in CEM-SS cells via
immunostaining
CEM-SS cells (10
6cells/mL) were harvested by centrifu-
gation at 130 g for 5 minutes and washed 3 times in
phosphate buffered saline (PBS) (pH 7.4). The washed
cells were fixed using 4% paraformaldehyde for 10 min-
utes and smears were prepared on poly-L-lysine coated
slides. The smears were dried overnight at room tem-
perature. The smear was covered with 0.1% H2O2 in
PBS for 10 minutes to quench endogenous peroxidase
activity and rinsed 3 times with PBS. Non-specific bind-
ing was blocked using 10% BSA in PBS for 20 minutes.
After 3 times washing in PBS, the smear was incubated
with 100 μg/mL of trypsin activated Bt18 parasporal
protein for 1 hour. The smear was washed 3 times in
PBS and primary antibody (anti-Bt18 antibody, 1:1000)
was added and incubated for 1 hour at room tempera-
ture. Then the smear was washed 3 times and incubated
with secondary antibody horseradish peroxidase (HRP)
labeled (1: 5000) for 45 minutes at room temperature.
The smear was washed 3 times with PBS and rinsed
with 0.5% triton X-100 in PBS for 30 seconds. Freshly
prepared liquid DAB substrate solution (DakoCytoma-
tion) was incubated for 5 minutes. After rinsing with
distilled water, the smear was counterstained with hae-
matoxylin for 3 seconds.
Detection of Bt18 binding protein using toxin
overlay blot
To identify the Bt18 binding protein, two methods were
used to prepare the cell binding protein containing sam-
ple. In one of the method, membrane proteins were pre-
pared from CEM-SS cells by using Mem-PER Eukaryotic
Membrane Protein Extraction Reagent Kit (Pierce). In
the second method, CEM-SS cells lysate was prepared
by sonication method. The membrane proteins and
CEM-SS cells lysate were separated by SDS-PAGE and
electrophoretically transferred to a nitrocellulose mem-
brane. Membrane was blocked with 5% (w/v) bovine
serum albumin (BSA) in tris buffered saline TBS
(pH 7.4) for 2 hours at room temperature. This was fol-
lowed by overnight incubation with 250 μg/mL of Bt18
parasporal protein at 4°C. Excess toxin was removed by
5 × 5 minutes washes with TBS (pH 7.4). The blot was
then incubated with anti-Bt18 antibody (1:1000) for 1 hr
at room temperature. The membrane was washed 5 × 5
minutes washes with TBS (pH 7.4) and incubated with
secondary antibody HRP labeled (1:5000) for 1 hour at
room temperature. After washing 5 × 5 minutes washes
with TBS (pH 7.4), the membrane was developed with
4-chloro-1-naphtol substrate.
N-terminal protein sequencing of binding protein
The identified binding protein was separated by SDS-
PAGE and transferred to a PVDF membrane, stained
with 0.1% Coomassie stain in 50% methanol, 7% acetic
acid for 2 minutes. The membrane was de-stained in
50% methanol, 7% acetic acid, for 10 minutes. To com-
pletely de-stain the background, the membrane was
incubated in 90% methanol, 10% acetic acid for 10 min-
utes. The membrane was sent to Vivantis Technolo-
gies-Biomolecular Research Facility-Newcastle Protein,
Applied Biosystem - PROCISE (University of Newcas-
tle, Australia) for N-terminal protein sequencing. The
15 amino acid sequence was analysed using the Basic
Local Alignment Search Tool (BLAST), at the National
Center for Biotechnology Information (NCBI) website
http://blast.ncbi.nlm.nih.gov/Blast.cgi.
Detection of GAPDH in CEM-SS cell lysate via immunoblot
assay
CEM-SS cell lysate was prepared by sonication method
and separated by SDS-PAGE. The separated cell lysate
was transferred to a nitrocellulose membrane using
Mini Trans-Blot Electrophoretic transfer cell (Bio-Rad).
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albumin (BSA) in tris buffered saline TBS (pH 7.4) for
2 hours at room temperature. The membrane was then
incubated with anti-GAPDH antibody (1:2000) for 1 hr
at room temperature. The membrane was washed 5 ×
5 minutes washes with TBS (pH 7.4) and incubated with
secondary antibody HRP labeled (1:5000) for 1 hour at
room temperature. After washing 5 × 5 minutes washes
with TBS (pH 7.4), the membrane was developed with
4-chloro-1-naphtol substrate.
Detection of Bt18 and GAPDH on CEM-SS cells via
immunofluorescent staining
CEM-SS cells (1 × 10
6 cells/mL) were harvested by cen-
trifugation at 130 × g for 5 minutes and washed 3 ×
5 minutes with PBS. The cells were resuspended in PBS
and smears were prepared by dropping the cell suspen-
sion onto poly-L-lysine coated slides. The smears were
left for 1 hour to allow the cells to adhere to the slides.
Next the cells were fixed in 4% paraformaldehyde for
15 minutes and washed with PBS briefly. Non specific
binding was blocked using 5% BSA in PBS for 20 min-
utes. The smear was washed 3 × 5 minutes with PBS.
After washing, the smear was incubated with 100 μg/mL
of solubilised and activated Bt18 parasporal protein for
1.5 hours. The cells were treated with a mixture of two
primary antibodies, rabbit polyclonal anti-Bt18 (1:10)
and mouse monoclonal anti-GAPDH (1:1000, Abcam)
for 1 hour at room temperature and labeled with a mix-
ture of fluorescent dye-conjugated secondary antibodies,
Texas Red-labeled anti-rabbit (1:200, Abcam) and Fluor-
escein (FITC)-labeled anti-mouse (1:128, Abcam) for
1 hour at room temperature in the dark. Finally, the
cells were counterstained with 0.1 μg/mL Hoechst blue
nuclear stain for 10 minutes. Negative controls included
the omission of Bt18 parasporal protein, omission of
primary antibodies (anti-Bt18 and anti-GAPDH anti-
body), and omission of secondary antibodies (Texas-Red
and FITC).
Confirmation of Bt18 binding to GAPDH via
immunofluorescent staining
In order to confirm the binding of Bt18 parasporal pro-
tein to GAPDH in CEM-SS cells, the immunofluores-
cent staining protocol (as described above) was modified
by incubating the slide with anti-GAPDH antibody
(dilution 1: 1000, Abcam) for 1 hour before the step for
adding 100 μg/mL Bt18 parasporal protein was taken.
A similar slide without the anti-GAPDH antibody incu-
bation step was prepared stimultaneously as positive
control. Both slides were later viewed under fluores-
cence microscopy and compared for fluorescence
intensity.
Results
Separation of Bt18 parasporal protein
Upon solubilisation in sodium carbonate buffer (pH 10.5)
and trypsin activation, Bt18 showed an abundant poly-
peptide band of 68-kDa and low molecular weight poly-
peptides ranging from 20-75-kDa (lane 2, Figure 1B). The
68-kDa parasporal protein was separated using Mono Q
anion exchange column as shown in the chromatogram
(Figure 1A). The 68-kDa Bt18 parasporal protein was
eluted in the major peak (fraction 4-6) as evident in the
SDS-PAGE gel (Figure 1B) with a reduction in the low
molecular weight peptides. However, as the lower mole-
cular weight polypeptides were still present in the puri-
fied fraction, the 68-kDa protein was eluted from the gel
by passive elution, overnight. This gel eluted 68-kDa pro-
tein was used to raise antibody.
Immunoblot assay to detect the binding of anti-Bt18
antibody to Bt18 parasporal protein
The immunoblot assay was performed to detect the
binding of anti-Bt18 antibody to Bt18 parasporal pro-
tein. The immunoblot showed specific binding of the
antibody to the parasporal protein at approximately
68-kDa as shown in Figure 2B, whereby Figure 2A is the
corresponding SDS-PAGE profile of Bt18 parasporal
protein. Interesting to note that cross-reactive binding
was not observed on other polypeptides of Bt18 para-
sporal proteins, indicating the specificity of the antibody
towards the 68-kDa parasporal protein. Sensitivity assay
was also carried out using indirect ELISA method to
evaluate the sensitivity of anti-Bt18 antibody on Bt18
parasporal protein. The result revealed that the antibody
can detect as low as 25 ng/mL of Bt18 parasporal
proteins.
Immunostaining
Strong immunostain (brownish ring formation) were
observed around the CEM-SS cells (Figure 3B) treated
with Bt18 indicating possible localisation of Bt18 para-
sporal protein binding on plasma membrane periphery.
The negative control cells (untreated) were observed as
immuno-negative (Figure 3A) as no brown stains were
observed.
Receptor binding assay
The membrane proteins used for the identification of
putative receptor was harvested from CEM-SS cells using
Mem-PER Eukaryotic Membrane Protein Extraction
Reagent Kit. Harvested membrane proteins were sub-
jected to detergent removal via dilution and dialysis using
Slide-A-lyzer® MINI Dialysis unit. The dialysate was sub-
jected to SDS-PAGE to evaluate the protein component,
however it was noted that many polypeptides were absent
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Page 4 of 11Figure 1 A. HPLC Chromatogram of trypsin activated Bt18 parasporal protein. Trypsin activated parasporal protein was applied to a Mono
Q exchange column with 20 mM Piperazine buffer (pH 9.8). The column was set to run at 1.0 mL/min with the salt gradient (0-1 M NaCl).
B. SDS-PAGE profile of Mono Q purified trypsin activated Bt18 parasporal protein. Coomassie Blue stained SDS 10% polyacrylamide gel.
Lane 1: Molecular weight marker; Lane 2: Solubilised and activated Bt18 parasporal protein; Lane 3: HPLC Fraction 3; Lane 4: HPLC Fraction 4;
Lane 5: HPLC Fraction 5; Lane 6: HPLC Fraction 6.
Figure 2 Immunoblot assay to detect the binding of anti-Bt18 antibody to Bt18 parasporal protein; (A): SDS-PAGE gel; (B): western
blot. The detection of binding of anti-Bt18 antibody to Bt18 parasporal protein was performed as described in the methods section. Lane 1:
Molecular weight marker; Lane 2: Bt18 parasporal protein. (Arrow indicates binding at approximately 68-kDa)
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teins should be in this fraction). We observed instead
that most polypeptides were present in the hydrophilic
fraction and not in the hydrophobic fraction, indicating
that the harvest of the membrane proteins were not very
efficient. After many and varied attempts, the detection
of the putative receptor with membrane proteins har-
vested was not successful. For example, no binding was
observed when the membrane proteins were incubated
with the unpurified or purified Bt18 parasporal proteins.
To overcome this difficulty, the putative receptor for
Bt18 parasporal proteins was studied using freshly pre-
pared CEM-SS cells lysate incubated with freshly acti-
vated Bt18 parasporal proteins. The binding protein for
Bt18 parasporal protein was successfully identified as
shown in Figure 4B (Lane 2). The binding protein had a
molecular weight between 25-37-kDa (estimated
36-kDa). The 15 amino acids sequence obtained were G-
K-V-K-V-G-V-N-G-F-G-R-I-G-G (Gly-Lys-Val-Lys-
Val-Gly-Val-Asn-Gly-Phe-Gly-Arg-Ilc-Gly-Gly).T h e
amino acid sequence was analysed using the NCBI
BLASTP; Swiss-Prot database and identified as G3P-
Human-Glyceraldehyde-3-phosphate-dehydrogenase
(GAPDH). The Alignment Score was 44.8 Bits and the
expectation value (E-value) was 3 × 10
-5 [Swiss-Prot:
P04406]. 14 of 15 amino acid sequence in the N-terminal
of binding protein showed 100% match to the N-terminal
of human GAPDH
Detection of GAPDH in CEM-SS cell lysate via immunoblot
assay
T h ei m m u n o b l o ts h o w e das p e c i f i cb i n d i n ga tas i n g l e
polypeptide band of a molecular weight of 25-37 kDa
(Figure 5B). It was concluded that the polypeptide is
Figure 3 Immunostaining of CEM-SS cells incubated with Bt18 parasporal protein. The binding of Bt18 parasporal protein on CEM-SS cells
was detected using immunostaining as described in the methods section. (A)- CEM-SS cells without Bt18 (negative control); (B)- CEM-SS cells
incubated with Bt18. (1000× magnification) (Arrow pointing at the brownish ring formation).
Figure 4 Toxin overlay blot with Bt18 parasporal protein. Toxin overlay blot was prepared as described in the methods section. (A): SDS-
PAGE gel; (B): western blot. Lane 1: Molecular weight marker; Lane 2: CEM-SS cells lysate; Lane 3: Diluted membrane proteins (hydrophobic
fraction); Lane 4: Undiluted membrane proteins (hydrophobic fraction); Lane 5: Hydrophilic fraction; Lane 6: Bt18 parasporal protein; 1 mg/mL;
Lane 7: Bt18 parasporal protein; 0.5 mg/mL (Arrow pointing at the binding protein).
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GAPDH antibody (Abcam). The molecular weight and
gel position of the polypeptide corresponds with the
binding protein of Bt18 parasporal protein in CEM-SS
cells.
Detection of Bt18 and GAPDH in CEM-SS cells via
immunofluorescence staining
In the double immunofluorescent staining, anti-Bt18 anti-
body was used as a probe to detect the binding of Bt18
parasporal protein in the CEM-SS cells while anti-
GAPDH antibody was used to detect the expression of
GAPDH in the CEM-SS cells. Figure 6(C) showed red
fluorescence signals around the cells indicating localisation
of Bt18 parasporal protein in the plasma membrane of the
cells. Figure 6(F) showed the expression of GAPDH in the
CEM-SS cells proven by emission of green fluorescence
signals around the cells as well. The double immunofluor-
escence image (Figure 7) suggested that Bt18 parasporal
protein and GAPDH are co-localised in the plasma mem-
brane of CEM-SS leukaemic cells.
Confirmation of Bt18 binding to GAPDH via
immunofluorescence staining
To corroborate the possibility of Bt18 binding to
GAPDH on plasma membrane of CEM-SS cells, anti-
GAPDH antibody was used to block the GAPDH
expressed on the plasma membrane. The cells were first
incubated with anti-GAPDH antibody before treating
with Bt18 parasporal protein. Figure 8A showed the
image of the slide without anti-GAPDH antibody incu-
bation and Figure 8B showed the image of the slide with
anti-GAPDH antibody incubation before treating the
cells with Bt18 parasporal protein. By using a red fluor-
escent to detect the binding of Bt18 to CEM-SS cells it
was noted that there was a decrease in the intensity of
fluorescence signals around the cells in the slide with
anti-GAPDH antibody incubation (Figure 8B) as com-
pared to the cells without anti-GAPDH antibody incu-
bation (Figure 8A). The decrease in fluorescence
intensity suggested that less Bt18 bound to the cells due
to less available binding sites.
Discussion
We began our study with purification of the Bt18 para-
sporal protein as it was a necessary step for raising anti-
bodies against Bt18. When Bt18 parasporal protein was
applied to a Mono Q 5/50 GL anion exchange column,
this step led to the separation of a 68-kDa protein from
the solubilised and activated parasporal protein. The
cytotoxicity of the 68-kDa protein against CEM-SS cells
was found to be reduced by 20% compared to the
Figure 5 Immunoblot assay to detect the expression GAPDH in CEM-SS cells crude cell lysate. Immunoblot assay was carried out as
mentioned in the methods section. (A): SDS-PAGE gel; (B): western blot. Lane 1: Molecular weight marker; Lane 2: CEM-SS cells crude lysate (5.0
mg/mL) (Arrow points to approximately 36-kDa, the estimated molecular weight of GAPDH).
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tein. This could possibily be due to the loss of polypep-
tides after separation, that were present in unseparated
parasporal protein [14].
In order to localise the binding site for the Bt18 para-
sporal protein, we performed immunostaining of the
CEM-SS cells with anti Bt18 antibodies. Antibody
against Bt18 was successfully raised and detected in rab-
bit sera as early as three weeks after primary immunisa-
tion (data not shown). The sensitivity of the antibody
raised was studied using immunoblot assay and strong
binding was observed on the immunoblot developed
with the anti-Bt18 antibody. Microscopic observation
revealed that Bt18 parasporal protein was distributed at
the cell periphery of CEM-SS (Figure 3) suggesting that
the protein may bind to a receptor on the plasma mem-
brane of cells. A study on parasporin-2 action on Hepa-
tocyte cancer cells (HepG2) showed that the parasporal
protein was detected at the cell periphery after incuba-
tion. Parasporin-2 was mostly distributed at the plasma
membrane because the immunostaining pattern of these
Figure 6 Double immunofluorescence staining - detection of Bt18 binding to CEM-SS cells and detection of GAPDH expression in
CEM-SS cells. (400× magnification). (Scale bar = 50 μm). (A) Binding of Bt18 on CEM-SS cells detected using a Texas Red filter. (B) Nucleus of
CEM-SS cells detected using a Hoechst filter. (C) Superimposed images of (A) and (B). (D) Detection of GAPDH expression CEM-SS cells using
FITC filter. (E) Nucleus of CEM-SS cells detected using a Hoechst filter. (F) Superimposed images of (D) and (E).
Figure 7 Double immunofluorescence staining - colocalisation
of Bt18 and GAPDH in CEM-SS cells, merged images of Figure
6(C) and Figure 6(F). Yellow fluorescence signals indicate co-
localisation of Bt18 and GAPDH.
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tribution of cadherin, a cell-cell adhesion protein in the
plasma membrane [15]. The study concluded that para-
sporin-2 was localised in the lipid raft of plasma mem-
brane before and during the membrane damage and
subsequently induces cell death. Similarly Bt18 para-
sporal protein was localised at the cell periphery during
its activity suggesting that Bt18 parasporal protein and
parasporin-2 may share similar mode of action.
To further elucidate the mode of action of Bt18 para-
sporal protein, we first determined the binding protein or
putative receptor in CEM-SS cells during interaction
with Bt18 parasporal protein. Interestingly Bt18 para-
sporal protein showed binding to a protein identified as
GAPDH, which was present in the CEM-SS cell lysate.
The interaction of Bt18 parasporal protein to GAPDH
was further verified using purified 68-kDa protein [16].
The binding of a Bt parasporal protein to GAPDH has
not been reported. To confirm Bt-GAPDH binding, we
used double immunofluorescence microscopic studies.
Red fluorescence signals around the cells indicating Bt18
is likely to bind on the plasma membrane of the cells
(Figure 6C). The detection of GAPDH expression on
CEM-SS cells (Figure 6F) showed green fluorescence sig-
nals seen around the cells indicating GAPDH is
expressed on the plasma membrane of the cells as well.
When both of the images were merged (Figure 7), a yel-
low fluorescence signal was produced around the cells,
indicating co-localisation of Bt18 and GAPDH at the
plasma membrane of the cells. To further confirm the
binding of Bt18 parasporal protein to GAPDH in the leu-
kaemic cells, we carried out immunostaining by first
blocking GAPDH with anti-GAPDH antibody before
incubating the cells with Bt18 parasporal protein. The
results showed a reduction in the binding of Bt18 to the
CEM-SS cells when compared with the slide without
anti-GAPDH incubation (Figure 8). This further suggests
that Bt18 binds to GAPDH on the cell membrane.
First discovered as one of the key enzymes involved in
glycolysis, GAPDH exert several functions as diverse as
apoptosis induction, receptor-associated kinase, tRNA
export or DNA repair [17]. These functions have been
linked to the various intracellular localisations of the
enzyme, which has been found in the cytosol, nucleus,
ER-golgi-vesiculae, mitochondria, as well as associated
w i t ht h ep l a s m am e m b r a n e[ 1 8 , 1 9 ] .I n t e r e s t i n g l y ,X i n g
et al., (2004) [20] reported GAPDH as a target protein of
the saframycin antiproliferative agents for leukaemia and
tumour-derived cells, where it forms a ternary complex
with saframycin-related compounds and DNA, inducing
a toxic response in cells. A specific binding interaction
occurred between GAPDH, duplex DNA, and several
known members of the saframycin class of antiprolifera-
tive agents implicating a previously unknown molecular
mechanism of anti-proliferative activity. This suggests
that GAPDH may be a potential target for chemothera-
peutic intervention. In a separate study, it is known that
Bt18 causes cell death in CEM-SS via apoptosis, as
demonstrated by Active caspase 3/7, Annexin V and
TUNEL assays [13]. While in our study, we suggest that
the Bt18-GAPDH binding contributes a significant role
in the cell killing mechanism against CEM-SS cells. The
above said data supports the suggestion that GAPDH is
linked with apoptotic cell death.
Based on a qualitative analysis of the immunoblot and
immunofluorescence results, it was suggested that
GAPDH is a binding protein located on the plasma mem-
brane of CEM-SS cells for Bt18 parasporal protein. Lee
et al., (2001) [1] suggested that the cytotoxic mechanisms
of the anti-cancer parasporal proteins (parasporins) were
similar to Cry proteins, which is dependent on binding to
receptor(s) on the cell membranes. Previously, no reports
have identified a putative receptor for Bt parasporins.
However, it was reported that parasporin-2 was localised
in the plasma membrane after incubation in Hep-G2
cells. They suggested that the final destination of the
Figure 8 Confirmation of Bt18 binding to GAPDH via immunofluorescence staining. (Scale bar = 50 μm). (A) Without anti-GAPDH antibody
incubation. (B) With anti-GAPDH antibody incubation.
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Page 9 of 11toxin for killing cells should be on the cell surface where
the membrane damage occurs [2]. In a study on Bacillus
thuringiensis subsp. coreanensis A1519 strain, ligand blot-
ting analysis with cell membrane proteins of MOLT-4
and HeLa cells suggested that the bacterium was closely
correlated with the presence of specific binding proteins
with molecular sizes from 40 - 50-kDa in the cell mem-
brane of MOLT-4. Thus, the Bacillus thuringiensis subsp.
coreanensis A1519 strain may recognise and bind to a
cell death inducing membrane protein of MOLT-4, set-
ting the death signal [3].
Early studies have identified GAPDH as a membrane
bound protein [4] and 60-70% of total erythrocyte
GAPDH was found to be membrane associated [5]. In a
study on the biosynthesis of GAPDH in prostate cancer,
the presence of five isozymes of GAPDH in human
malignant cells were reported while only four were
detected in normal prostate tissue. This further sug-
gested that multiple forms of GAPDH may have diverse
roles in the cells [6]. Several studies reported an increase
of GAPDH expression in cancer cell lines [7,8] and
shows that it has roles in the neoplastic transformation
of hepatocytes [9], tumor cell motility and metastasis in
rat prostate adenocarcinoma tissue [10], and in the
detoxification of cisplatin and doxorubicin in cancer
cells [11]. A study using anti-sense oligodeoxynucleotide
of the GAPDH gene inhibited cell proliferation and
induced apoptosis in human cervical cancer cell lines
[12]. These reports provide evidences for the existence
of GAPDH isozymes and its functional diversities, which
raises the possibility of GAPDH to function as a recep-
tor in cancer cells for Bt parasporal proteins. The pre-
ferential toxicity of Bt18 to CEM-SS cells makes Bt18 a
possible chemotherapeutic agent alone or as a synergist
with current anticancer agents to enhance its cytotoxi-
city against cancer cells. Therefore, identification of a
receptor would provide insights to the mechanism of
action of Bt18 parasporal protein which is crucial in the
pharmacological understanding of Bt18.
It is noteworthy that GAPDH has been reported to be
expressed on the surface of macrophage membrane and
reported to function as novel transferrin receptor [33].
FACS analysis of monoclonal anti-GAPDH antibody
stained J774 mouse and human macrophage cell line
demonstrated that these cells express GAPDH on the
membrane surface. The presence of GAPDH on the
outer surface of intact J774 cell membrane was further
confirmed by immunolabelling followed by transmission
and electron microscopy. Interestingly the study also
indicated that mammalian GAPDH showed interaction
with human holo-transferin. Transferrin colocalises with
cell surface GAPDH as shown by confocal microscopy
of double immunoflourescence staining of intact J774
cells. GAPDH-transferrin interaction was further proved
using invitro ELISA assay and FRET analysis. GAPDH
was also noted to play a role in the induction of apopto-
sis by nuclear translocation of endogenous GAPDH.
Over expressed GAPDH that is translocated in the
nucleus preceding DNA damage robustly induced apop-
totic death [34]. Furthermore, in apoptotic cells,
GAPDH expression is three times higher than in non-
apoptotic cells. This could probably related to the activ-
ity of GAPDH as a DNA repair enzyme or as a nuclear
carrier for pro-apoptotic molecules [35] These findings
s u g g e s tt h a tt h e r em a yb ear o l ef o rG A P D Hi nt h e
mode of action for Bt18 parasporal protein. It is inter-
esting to note that Bt18 parasporal protein act like para-
sporins, as these proteins are non-haemolytic and
capable of preferentially killing leukaemic T cells. Thus,
binding of Bt18 parasporal protein to GAPDH is a sig-
nificant finding as literature shows that there have been
limited studies on identification of a binding protein for
parasporins in cancer cells.
Conclusion
We conclude that there is a binding protein in CEM-SS
cell for Bt18 parasporal protein. G3P-Human-Glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH) was iden-
tified as the binding protein of cytotoxic Bt18 parasporal
protein. The findings in this study warrant further inves-
tigations to determine the different isozymes present in
leukaemic cells compared to normal T-lymphocytes.
Future gene therapy against cancer specific GAPDH iso-
zymes might be another form of treatment in cancer.
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